Search results
Rhythm Interventions Online 2023 - On Demand
Video Series
Author(s):
Vijayabharathy Kanthasamy
,
Richard Schilling
Added:
3 years ago
Coronavirus disease 2019 (COVID-19) is caused by the novel betacoronavirus officially named by the WHO as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It has spread rapidly globally since the first case reported in Wuhan, China in December 2019 and has now affected more than 12million people worldwide, with varying fatality rates across different countries.1 The clinical…
View more
James C Moon
Job title: Clinical Director of Imaging
Author
Start date:
Nov 30, 2022
End date:
Dec 02, 2022
Rhythm Interventions Online will return 30 November – 2 December 2022
Now in its third year, the goal of RIO remains steadfast: To best support you, the healthcare practitioner, achieve the best possible clinical outcomes in electrophysiology practice.
Last year’s event brought together opinion leaders from 15 countries, seven live case centres, and a global audience of thousands.Click here to…
View more
Author(s):
Roberto Rordorf
Added:
1 year ago
The Promise of Leadless Pacing
Author(s):
Katrina Mountfort
,
Reinoud Knops
,
Johannes Sperzel
,
et al
Added:
3 years ago
Article
Author(s):
Joshua R Silverstein
,
Demosthenes G Katritsis
,
Mark E Josephson
Added:
3 years ago
Sudden cardiac death (SCD) is one of the leading causes of death in developed countries. The yearly incidence of SCD is estimated to be 3,000,000 worldwide and between 300,000–450,000 in both the US and Western Europe.1,2 The survival rate for SCD is <1 % worldwide and close to 5 % in the developed world.3 In the past, cardiac arrest was thought to be most commonly due to ventricular…
View more
Author(s):
Carlo Pappone
Added:
1 year ago
EHRA 23 - We are joined onsite by Prof Carlo Pappone (IRCCS Policlinico San Donato, IT) who outlines the key findings of the BRUGADA Randomized trial.
In a randomized controlled trial, 150 patients with Brugada syndrome were enrolled in to develop an evidence-based treatment for the condition. Patients were randomized in a 2:1 fashion to receive either catheter ablation treatment with an ICD, or…
View more
Author(s):
Ahmadreza Karimianpour
,
Leah John
,
Michael R Gold
Added:
2 years ago
Author(s):
Jagmeet P Singh
Added:
2 years ago
In this interview, Dr Jagmeet Singh (Massachusetts General Hospital, Harvard Medical School, Boston, MA, US) discusses the Phase I results of the Solve-CRT Study presented at ESC's Heart Rhythm Society event in 2021. This study is a multicenter pivotal trial, investigating the safety of the WiSE CRT System in leadless cardiac resynchronization therapy.
Questions:
1. Could you briefly remind us…
View more